Antibiotic

Medications taken years or even decades ago may still be altering your gut health today, reveals a recent study. Scientists found that antidepressants, beta-blockers, and anxiety meds, not just antibiotics, can leave long-term “fingerprints” on the gut microbiome, potentially impacting digestion, immunity, and wellbeing.

Taking too many antibiotics? Why overusing them today could fail you in future health emergencies

Antibiotics have long been seen as cure-all medicines, but their overuse is quietly fuelling antibiotic resistance. This growing crisis could leave common infections harder to treat. Doctors now warn it’s time to use antibiotics wisely, before we lose their power altogether. Here’s what you must know to stay safe.

Wockhardt shares rally 5% after Indian drug regulator approves Pneumonia antibiotic

Central Drugs Standard Control Organization (CDSCO) approved antibiotic Nafithromycin, sold under Miqnaf brand, as a new treatment for community-acquired bacterial Pneumonia (CABP) in adults.

India mandates justification for antimicrobial prescriptions in Medical Colleges

4.6 percent of patients were found to have taken four or more types of antibiotics according to a recent survey by the National Centre for Disease Control (NCDC)

Wockhardt has more antibiotics in the pipeline: Dr Habil Khorakiwala

Wockhardt could be more of a research company in five years than what it is today.

New India-UK research to trial easy-to-use test to cut antibiotic resistance

India has the highest human antibiotic use in the world and, if successful, the DOSA Project could significantly help in the prevention and treatment of UTIs and the appropriate use of antibiotics in the country.

DGTR recommends anti-dumping duty on Chinese Ceftriaxone Sodium Sterile, a key antibiotic

Ceftriaxone is used to treat critical medical conditions such as Meningitis, and was dumped at extremely low prices by Chinese producers in the Indian market.

COVID-19 first wave led to increase in antibiotic misuse in India: Study

The researchers at Washington University in the US estimated that COVID-19 likely contributed to 216.4 million excess doses of antibiotics and 38 million more doses of azithromycin in adults from June 2020 through September 2020, a period of peak COVID-19 activity in India.

Wockhardt shares up 7% as USFDA fast-tracks its new antibiotic in clinical trial

The US FDA move may help Wockhardt efforts to bring the drug early to market. Wockhardt said it expects global clinical launch of WCK 5222 during the year 2020-21.

Antidumping duty likely on ofloxacin imports from China

The Directorate General of Anti-Dumping and Allied Duties (DGAD), under the Commerce Ministry, has started the anti-dumping investigation concerning imports of "Ofloxacin" originating in or exported from China.

KFC China sues 3 companies amid chicken rumours

Yum Brands Inc's KFC unit in China said on Monday it has sued three companies it claims are using a popular messaging service to spread false rumours about the fried-chicken chain, including allegations that its chickens have six wings and eight legs.

Sun-Ranbaxy's $4bn merger deal gets USFTC's conditional nod

Approval subject to divestment of one antibiotic product to avoid anticompetitive impact in the US mkt.

Can we avoid an antibiotic apocalypse?

Since drugs such as penicillin are so widely used - if not abused - the bacteria they fight are now mutating and becoming resistant.

Venus Remedies soars 5% on Mexico patent for Potentox

Venus Remedies has received another patent from Mexico for its antibiotic Potentox. This patent provides an exclusivity period for Potentox upto 2025.

Panda's blood may help combat superbugs: Scientists

Giant pandas may be the latest weapon against superbugs after scientists have discovered a powerful antibiotic - that can destroy fungi and bacteria - in the blood of the endangered furry creatures.

Aurobindo Pharma gets US FDA nod for Nafcillin injections

Aurobindo Pharma on Thursday said it has received final approval from US Food and Drugs Administration to manufacture and market Nafcillin for Injection packaged in 1g and 2g vials and Nafcillin for Injection in 10g/vial pharmacy bulk package.

Strides Arcolab hits new high on US nod for antibiotic

Pharma company Strides Arcolab has received approval from US Food and Drugs Administration for Vancomycin Hydrochloride capsules of 125 mg and 250 mg strengths.

Antibiotics overprescribed for children: US study

Pediatricians in the United States write more than 10 million unnecessary antibiotic prescriptions every year for conditions such as the flu and asthma, contributing to potentially dangerous drug resistance, a study said.

Strides Arcolab gets US FDA nod for antibacterial injection

Pharma company Strides Arcolab has received approval from US Food and Drugs Administration (FDA) for Clindamycin injection, an antibiotic used to treat bacterial infections.

Aarti Drugs expects over Rs 700cr revenue in FY12

Harshit Savla, MD of Aarti Drugs, in an interview with CNBC-TV18’s Gautam Broker and Latha Venkatesh, spoke about the recent happenings in his company and the road ahead.